FIELD: chemistry.
SUBSTANCE: invention relates to spiro derivatives of parthenin of formula 
, where R/R' is selected from a group consisting of phenyl or a substituted phenyl such as 4-ClC6H4, 2-NO2C6H4; 2,4-(MeO)2C6H3, 4-MeC6H4, and formula 
, where R is 4-MeOC6H4, 2-NO2C6H4, 3-NO2C6H4, 3-MeC6H4, 3-MeCO2C6H4. The invention also relates to methods of producing said spiro derivatives and a pharmaceutical composition based on said derivatives.
EFFECT: compounds of formula 1b and 1d have anticancer activity.
14 cl, 6 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 3-ARYL-4-(TRIFLUOROMETHYL)-4H-SPIRO[CHROMENO[3,4-C]PYRROLIDINE-1,3'-OXINDOLES] HAVING HIGH CYTOTOXIC ACTIVITY AGAINST HUMAN UTERINE NECK CARCINOMA HeLa CELLS, AND THE METHOD FOR THEIR PREPARATION | 2021 |
|
RU2774705C1 |
| AZA-SUBSTITUTED SPIRO-DERIVATIVES | 2006 |
|
RU2428423C2 |
| PICOLINAMIDES AS FUNGICIDES | 2015 |
|
RU2686987C2 |
| COMPOUNDS USEFUL AS PESTICIDES, AND INTERMEDIATE COMPOUNDS, COMPOSITIONS AND METHODS RELATED THERETO | 2016 |
|
RU2821715C2 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| 3-SUBSTITUTED OXINDOLE DERIVATIVES AS MODULATORS OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1996 |
|
RU2165925C2 |
| N-HYDROXYLUREAS AS ANTI-INFLAMMATORY AGENTS | 1995 |
|
RU2152935C2 |
| METHYL-3-ARYL-3A-NITRO-4-(TRIFLUOROMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCHROMENO[3,4-C]PYRROLE-1-CARBOXYLATES, HAVING CYTOTOXIC ACTIVITY ON CELL LINE HUMAN CERVICAL CARCINOMA HELA, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818191C1 |
| SPIRO- OR DISPIRO-1,2,4-TRIOXOLANE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 2002 |
|
RU2271357C2 |
| NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
